TY - JOUR T1 - Healthcare Asset Due Diligence: <em>Risks and Opportunities</em> JF - The Journal of Private Equity SP - 26 LP - 30 DO - 10.3905/jpe.2015.18.4.026 VL - 18 IS - 4 AU - J. Mark Pohl Y1 - 2015/08/31 UR - https://pm-research.com/content/18/4/26.abstract N2 - Current healthcare due diligence leaves investors with a critical blind spot: due diligence is unable to identify an intellectual property variable that determines investment outcomes. This article shows how to find that variable, discusses case studies illustrating how that variable creates or destroys value, and provides a reliable framework to assure that your due-diligence team provides guidance that is not merely correct, but effective.TOPICS: Private equity, risk management, other real assets, manager selection ER -